Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL2058739

O=S(=O)(O)C(F)(F)F.Sc1ccccc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.42
TSHR P16473 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA5A P35218 1/20 0.39
CA9 Q16790 1/20 0.39
CES1 P23141 2/20 0.37
ALDH1A1 P00352 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GPR3 P46089 1/20 0.34
HSD11B1 P28845 1/20 0.34
SRC P12931 1/20 0.33
HTR6 P50406 1/20 0.33
POLB P06746 1/20 0.32
CYP2D6 P10635 1/20 0.32
FAAH O00519 1/20 0.32
PRSS1 P07477 1/20 0.32
PRSS2 P07478 1/20 0.32
ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL29587491 1.00 PTPN1 (0.42) PTPN1TSHRSMN1; SMN2CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL31473545 0.88 PTPN1 (0.53) PTPN1CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL562439 0.86 IDO1 (0.48) PTPN1TSHRSMN1; SMN2CES1ALDH1A1
Benzenethiol SCHEMBL11884916 0.83 TSHR (0.46) TSHRSMN1; SMN2CA1CA2CA5A
Biphenyl SCHEMBL27775707 0.83 MMP3 (0.47) PTPN1
Trifluoromethanesulfonic Acid SCHEMBL17907399 0.83 CA1 (0.44) PTPN1TSHRSMN1; SMN2CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL17835417 0.83 MMP13 (0.41) PTPN1TSHRSMN1; SMN2CA1CA2
Benzenethiol SCHEMBL11884719 0.83 TSHR (0.50) TSHRSMN1; SMN2CA1CA2CA5A
Biphenyl SCHEMBL1993781 0.82 PTPN1 (0.44) PTPN1SMN1; SMN2CA1CA2CA5A
Biphenyl SCHEMBL1050411 0.81 PTPN1 (0.58) PTPN1TSHRSMN1; SMN2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250354031-A1 Transparent Omniphobic Coatings UNIV KINGSTON (CA) 2025-11-20 US disclosed
US-20240369924-A1 RESIST COMPOSITION AND RESIST FILM FORMING METHOD USING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-11-07 US disclosed
CN-115368494-B Monomer copolymer containing hexafluoroisopropanol, preparation method thereof, chemical amplification type photoresist and application thereof 瑞红(苏州)电子化学品股份有限公司 2024-03-29 CN disclosed
CN-111234236-B Siloxane polymer containing isocyanuric acid and polyether skeleton, photosensitive resin composition, and pattern formation method 信越化学工业株式会社 2023-03-24 CN disclosed
CN-108388082-B Photosensitive resin composition, photosensitive dry film, photosensitive resin coating and pattern forming method 信越化学工业株式会社(JP) 2023-01-13 CN disclosed
CN-115368494-A Hexafluoroisopropanol-containing monomer copolymer, preparation method thereof, chemical amplification type photoresist and application 瑞红(苏州)电子化学品股份有限公司 2022-11-22 CN disclosed
EP-2384457-B1 COATING COMPOSITIONS MERCK PATENT GMBH (DE) 2022-07-06 EP disclosed
US-11118082-B2 Composition, insulating material, and method for preparing an insulating material INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2021-09-14 US disclosed
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) 2021-02-23 US disclosed
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2020-08-13 US disclosed
US-6136783-A Antifungal compositions MERCK & CO., INC. (US) 2000-10-24 US disclosed
US-6132644-A Energy sensitive electrically conductive admixtures INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2000-10-17 US disclosed
US-5952300-A CYCLIC PEPTIDE FUNGICIDE FOR INTRAVENOUS ADMINISTRATION MERCK & CO., INC. (US) 1999-09-14 US disclosed
US-5936062-A Process for preparing certain aza cyclohexapeptides MERCK & CO., INC. (US) 1999-08-10 US disclosed
EP-0912603-A1 A PROCESS FOR PREPARING CERTAIN AZA CYCLOHEXAPEPTIDES Merck & Co., Inc. (US) 1999-05-06 EP disclosed
WO-1997047645-A1 A PROCESS FOR PREPARING CERTAIN AZA CYCLOHEXAPEPTIDES MERCK & CO., INC. (US) 1997-12-18 WO disclosed
EP-0808330-A1 A PROCESS FOR PREPARING CERTAIN AZA CYCLOHEXAPEPTIDES Merck & Co., Inc. (US) 1997-11-26 EP disclosed
US-5552521-A REDUCTION OF PRIMARY AMIDE, STEREOSELECTIVE AMINATION MERCK & CO., INC. (US) 1996-09-03 US disclosed
WO-1996024613-A1 A PROCESS FOR PREPARING CERTAIN AZA CYCLOHEXAPEPTIDES MERCK & CO., INC. (US) 1996-08-15 WO disclosed
EP-0377175-A2 Pattern forming composition and process for forming pattern using the same HITACHI, LTD. (JP) 1990-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES SLC35B2, PPIP5K2, PPA1 PTPN1 184/4885TSHR 733/4885SMN1; SMN2 4720/4885
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates SLC35B2, PPIP5K2, PPA1 PTPN1 184/4885TSHR 733/4885SMN1; SMN2 4720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.